Zobrazeno 1 - 10
of 477
pro vyhledávání: '"Richard T. Hoppe"'
Autor:
Jean‐Pierre Obeid, Susan M. Hiniker, Joseph Schroers‐Martin, H. Henry Guo, Hyunsoo Joshua No, Everett J. Moding, Ranjana H. Advani, Ash A. Alizadeh, Richard T. Hoppe, Michael S. Binkley
Publikováno v:
eJHaem, Vol 4, Iss 1, Pp 90-99 (2023)
Abstract Low‐grade lymphomas have a 1%–3% annual risk of transformation to a high‐grade histology, and prognostic factors remain undefined. We set to investigate the role of positron emission tomography (PET) metrics in identification of transf
Externí odkaz:
https://doaj.org/article/87a9d41a9abc4fd7b16b47b5c9d6db05
Autor:
Erik S. Blomain, MD, PhD, Alice Jiang, BA, Sarah S. Donaldson, MD, Rajni Agarwal, MD, Alice Bertaina, MD, PhD, David Shyr, MD, Michael L. Eisenberg, MD, Richard T. Hoppe, MD, Susan M. Hiniker, MD, Justin Oh, MD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 1, Pp 101071- (2023)
ABSTRACT: Purpose: Children with leukemia who receive fractionated total body irradiation (fTBI) with 12 to 13.2 Gy as part of conditioning for hematopoietic stem cell transplant are frequently treated with an additional 4 Gy testicular boost to redu
Externí odkaz:
https://doaj.org/article/0ef718d082bc4b0d8260bd421c20d5ba
Publikováno v:
Technical Innovations & Patient Support in Radiation Oncology, Vol 18, Iss , Pp 12-15 (2021)
Externí odkaz:
https://doaj.org/article/2190e05021db489cbbd21d0b65b615ae
Autor:
Sophia Fong, BS, Eric K. Hong, BS, Michael S. Khodadoust, MD, PhD, Shufeng Li, MS, Richard T. Hoppe, MD, Youn H. Kim, MD, Susan M. Hiniker, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 3, Pp 100629- (2021)
Purpose: Management of patients with refractory mycosis fungoides and Sézary syndrome (SS) is often challenging, as available therapies lack durable response and consistent activity across disease compartments. Combining low-dose total skin electron
Externí odkaz:
https://doaj.org/article/3c4de9e5a94d4950a7dd86d9966239fc
Autor:
Michael A. Spinner, Vanessa E. Kennedy, John S. Tamaresis, Philip W. Lavori, Sally Arai, Laura J. Johnston, Everett H. Meyer, David B. Miklos, Lori S. Muffly, Robert S. Negrin, Andrew R. Rezvani, Judith A. Shizuru, Wen-Kai Weng, Richard T. Hoppe, Samuel Strober, Robert Lowsky
Publikováno v:
Blood Advances, Vol 3, Iss 16, Pp 2454-2464 (2019)
Abstract: Nonmyeloablative total lymphoid irradiation and antithymocyte globulin (TLI-ATG) conditioning is protective against graft-versus-host disease (GVHD), while retaining graft-versus-tumor activity across various hematologic malignancies. We re
Externí odkaz:
https://doaj.org/article/43899d6eaf0e47758cc194b59604146d
Publikováno v:
Blood Advances, Vol 2, Iss 13, Pp 1547-1550 (2018)
Externí odkaz:
https://doaj.org/article/b344f85483fc4739b2b392f4f748e8da
Autor:
Iris Amitay-Laish, MD, Uma Sundram, MD, PhD, Richard T. Hoppe, MD, Emmilia Hodak, MD, Bruno C. Medeiros, MD, Youn H. Kim, MD
Publikováno v:
JAAD Case Reports, Vol 3, Iss 4, Pp 310-315 (2017)
Externí odkaz:
https://doaj.org/article/fb55bfc6e22842e18503021b5c770d53
Autor:
Jean‐Pierre Obeid, Susan M. Hiniker, Joseph Schroers‐Martin, H. Henry Guo, Hyunsoo Joshua No, Everett J. Moding, Ranjana H. Advani, Ash A. Alizadeh, Richard T. Hoppe, Michael S. Binkley
Publikováno v:
eJHaem. 4:90-99
Autor:
Scott J. Rodig, Margaret A. Shipp, Donna S. Neuberg, Richard T. Hoppe, Daphne de Jong, Bjoern Chapuy, Sarah E. Daadi, Christopher D. Carey, Christine J. Pak, Courtney F. Connelly, Azra H. Ligon, Yasodha Natkunam, Geraldine S. Pinkus, Robert A. Redd, Ranjana H. Advani, Margaretha G.M. Roemer
Supplementary methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6729a4074d7b2f0c5c5b004c9714fb03
https://doi.org/10.1158/2326-6066.22538633
https://doi.org/10.1158/2326-6066.22538633
Autor:
Scott J. Rodig, Margaret A. Shipp, Donna S. Neuberg, Richard T. Hoppe, Daphne de Jong, Bjoern Chapuy, Sarah E. Daadi, Christopher D. Carey, Christine J. Pak, Courtney F. Connelly, Azra H. Ligon, Yasodha Natkunam, Geraldine S. Pinkus, Robert A. Redd, Ranjana H. Advani, Margaretha G.M. Roemer
In classical Hodgkin lymphoma (cHL), malignant Hodgkin Reed–Sternberg (HRS) cells evade antitumor immunity by multiple mechanisms, including perturbed antigen presentation and enhanced PD-1 signaling. HRS cell expression of the PD-1 ligands is attr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68175a95cddbc1b70abf8692f721269c
https://doi.org/10.1158/2326-6066.c.6548840.v1
https://doi.org/10.1158/2326-6066.c.6548840.v1